The role of allopregnanolone in pregnancy in predicting postpartum anxiety symptoms

Research output: Contribution to journalArticle

Abstract

Postpartum depression is a serious illness affecting up to 15% of women worldwide after childbirth, and our understanding of its biology is limited. Postpartum anxiety is perhaps more prevalent and less understood. Prior studies indicate that allopregnanolone, a metabolite of progesterone, may play a role in reproductive mood disorders, including postpartum depression, but the exact nature of that role is unclear. Our own prior study in a group of psychiatrically ill women found that low allopregnanolone in the second trimester predicted the development of postpartum depression. In the present study, in both healthy and mood- and anxiety-disordered women who remained well throughout the perinatal period, we found that second trimester allopregnanolone predicted postpartum anxiety symptoms, with a similar trend toward the prediction of postpartum depressive symptoms (though without statistical significance). Both concurrent sleep and prior histories of mood and anxiety disorders contributed to the variance in mood and anxiety scores at 6 weeks postpartum. These findings confirm the importance of pregnancy allopregnanolone in postpartum psychiatric symptoms and point to future directions that may determine other important contributing factors.

Original languageEnglish (US)
Article number1033
JournalFrontiers in Psychology
Volume10
Issue numberJULY
DOIs
StatePublished - Jan 1 2019

Fingerprint

Pregnanolone
Postpartum Period
Anxiety
Postpartum Depression
Pregnancy
Second Pregnancy Trimester
Mood Disorders
Anxiety Disorders
Progesterone
Psychiatry
Sleep
Parturition
Depression

Keywords

  • Allopregnanolone
  • Anxiety
  • Depression
  • Hormones
  • Postpartum
  • Pregnancy

ASJC Scopus subject areas

  • Psychology(all)

Cite this

The role of allopregnanolone in pregnancy in predicting postpartum anxiety symptoms. / Osborne, Lauren; Betz, Joshua Francis; Yenokyan, Gayane; Standeven, Lindsay R.; Payne, Jennifer.

In: Frontiers in Psychology, Vol. 10, No. JULY, 1033, 01.01.2019.

Research output: Contribution to journalArticle

@article{8558a019d10c48d5824a24fbca2eaaf4,
title = "The role of allopregnanolone in pregnancy in predicting postpartum anxiety symptoms",
abstract = "Postpartum depression is a serious illness affecting up to 15{\%} of women worldwide after childbirth, and our understanding of its biology is limited. Postpartum anxiety is perhaps more prevalent and less understood. Prior studies indicate that allopregnanolone, a metabolite of progesterone, may play a role in reproductive mood disorders, including postpartum depression, but the exact nature of that role is unclear. Our own prior study in a group of psychiatrically ill women found that low allopregnanolone in the second trimester predicted the development of postpartum depression. In the present study, in both healthy and mood- and anxiety-disordered women who remained well throughout the perinatal period, we found that second trimester allopregnanolone predicted postpartum anxiety symptoms, with a similar trend toward the prediction of postpartum depressive symptoms (though without statistical significance). Both concurrent sleep and prior histories of mood and anxiety disorders contributed to the variance in mood and anxiety scores at 6 weeks postpartum. These findings confirm the importance of pregnancy allopregnanolone in postpartum psychiatric symptoms and point to future directions that may determine other important contributing factors.",
keywords = "Allopregnanolone, Anxiety, Depression, Hormones, Postpartum, Pregnancy",
author = "Lauren Osborne and Betz, {Joshua Francis} and Gayane Yenokyan and Standeven, {Lindsay R.} and Jennifer Payne",
year = "2019",
month = "1",
day = "1",
doi = "10.3389/fpsyg.2019.01033",
language = "English (US)",
volume = "10",
journal = "Frontiers in Psychology",
issn = "1664-1078",
publisher = "Frontiers Research Foundation",
number = "JULY",

}

TY - JOUR

T1 - The role of allopregnanolone in pregnancy in predicting postpartum anxiety symptoms

AU - Osborne, Lauren

AU - Betz, Joshua Francis

AU - Yenokyan, Gayane

AU - Standeven, Lindsay R.

AU - Payne, Jennifer

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Postpartum depression is a serious illness affecting up to 15% of women worldwide after childbirth, and our understanding of its biology is limited. Postpartum anxiety is perhaps more prevalent and less understood. Prior studies indicate that allopregnanolone, a metabolite of progesterone, may play a role in reproductive mood disorders, including postpartum depression, but the exact nature of that role is unclear. Our own prior study in a group of psychiatrically ill women found that low allopregnanolone in the second trimester predicted the development of postpartum depression. In the present study, in both healthy and mood- and anxiety-disordered women who remained well throughout the perinatal period, we found that second trimester allopregnanolone predicted postpartum anxiety symptoms, with a similar trend toward the prediction of postpartum depressive symptoms (though without statistical significance). Both concurrent sleep and prior histories of mood and anxiety disorders contributed to the variance in mood and anxiety scores at 6 weeks postpartum. These findings confirm the importance of pregnancy allopregnanolone in postpartum psychiatric symptoms and point to future directions that may determine other important contributing factors.

AB - Postpartum depression is a serious illness affecting up to 15% of women worldwide after childbirth, and our understanding of its biology is limited. Postpartum anxiety is perhaps more prevalent and less understood. Prior studies indicate that allopregnanolone, a metabolite of progesterone, may play a role in reproductive mood disorders, including postpartum depression, but the exact nature of that role is unclear. Our own prior study in a group of psychiatrically ill women found that low allopregnanolone in the second trimester predicted the development of postpartum depression. In the present study, in both healthy and mood- and anxiety-disordered women who remained well throughout the perinatal period, we found that second trimester allopregnanolone predicted postpartum anxiety symptoms, with a similar trend toward the prediction of postpartum depressive symptoms (though without statistical significance). Both concurrent sleep and prior histories of mood and anxiety disorders contributed to the variance in mood and anxiety scores at 6 weeks postpartum. These findings confirm the importance of pregnancy allopregnanolone in postpartum psychiatric symptoms and point to future directions that may determine other important contributing factors.

KW - Allopregnanolone

KW - Anxiety

KW - Depression

KW - Hormones

KW - Postpartum

KW - Pregnancy

UR - http://www.scopus.com/inward/record.url?scp=85069541601&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85069541601&partnerID=8YFLogxK

U2 - 10.3389/fpsyg.2019.01033

DO - 10.3389/fpsyg.2019.01033

M3 - Article

C2 - 31379633

AN - SCOPUS:85069541601

VL - 10

JO - Frontiers in Psychology

JF - Frontiers in Psychology

SN - 1664-1078

IS - JULY

M1 - 1033

ER -